489 related articles for article (PubMed ID: 16172308)
21. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Estève E; Bagot M; Joly P; Souteyrand P; Beylot-Barry M; Vaillant L; Delaunay M; Avril MF; Laroche L; Grange F; Thomine E; Wechsler J
Arch Dermatol; 1999 Nov; 135(11):1349-53. PubMed ID: 10566833
[TBL] [Abstract][Full Text] [Related]
23. Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
Quereux G; Marques S; Nguyen JM; Bedane C; D'incan M; Dereure O; Puzenat E; Claudy A; Martin L; Joly P; Delaunay M; Beylot-Barry M; Vabres P; Celerier P; Sasolas B; Grange F; Khammari A; Dreno B
Arch Dermatol; 2008 Jun; 144(6):727-33. PubMed ID: 18559761
[TBL] [Abstract][Full Text] [Related]
24. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides.
Xiao T; Xia LX; Yang ZH; He CD; Gao XH; Chen HD
Eur J Dermatol; 2008; 18(6):660-2. PubMed ID: 18955199
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
[TBL] [Abstract][Full Text] [Related]
26. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
Thomsen K; Hammar H; Molin L; Volden G
Acta Derm Venereol; 1989; 69(6):536-8. PubMed ID: 2575334
[TBL] [Abstract][Full Text] [Related]
27. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
Vonderheid EC; Van Scott EJ; Wallner PE; Johnson WC
Cancer Treat Rep; 1979 Apr; 63(4):681-9. PubMed ID: 109206
[TBL] [Abstract][Full Text] [Related]
28. The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
Kim EJ; Guitart J; Querfeld C; Girardi M; Musiek A; Akilov OE; Angello JT; Bailey WL; Geskin LJ
Am J Clin Dermatol; 2021 May; 22(3):407-414. PubMed ID: 33656660
[TBL] [Abstract][Full Text] [Related]
29. Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies.
Zackheim HS; Epstein EH
Arch Dermatol; 1975 Dec; 111(12):1564-70. PubMed ID: 1200661
[TBL] [Abstract][Full Text] [Related]
30. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
31. Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience.
Garcia-Saleem TJ; Stonesifer CJ; Khaleel AE; Geskin LJ
Acta Derm Venereol; 2021 Sep; 101(9):adv00544. PubMed ID: 34436621
[TBL] [Abstract][Full Text] [Related]
32. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
[TBL] [Abstract][Full Text] [Related]
33. Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: a preliminary experience.
Parida DK; Verma KK; Chander S; Joshi RC; Rath GK
Int J Dermatol; 2005 Oct; 44(10):828-30. PubMed ID: 16207183
[TBL] [Abstract][Full Text] [Related]
34. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
35. Topical mechlorethamine therapy for mycosis fungoides. Proposed schedule to overcome drug resistance.
Volden G; Molin L; Thomsen K
Arch Dermatol; 1982 Feb; 118(2):138-9. PubMed ID: 7059219
[No Abstract] [Full Text] [Related]
36. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
[TBL] [Abstract][Full Text] [Related]
37. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
[TBL] [Abstract][Full Text] [Related]
38. [Narrow band UVB therapy in early stage mycosis fungoides. A study of 23 patients].
Coronel-Pérez IM; Carrizosa-Esquivel AM; Camacho-Martínez F
Actas Dermosifiliogr; 2007 May; 98(4):259-64. PubMed ID: 17506957
[TBL] [Abstract][Full Text] [Related]
39. Topical treatment of early cutaneous T-cell lymphoma.
Ramsay DL; Meller JA; Zackheim HS
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
[TBL] [Abstract][Full Text] [Related]
40. A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides.
Kamstrup MR; Specht L; Skovgaard GL; Gniadecki R
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1204-7. PubMed ID: 18207669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
